My take: The release states TLX101 is currently second line treatment. TLX are stopping this second line trial and plan to move it into first line therapy trial on encouraging results: Whilst a small study of ten patients, promising overall survival and anti-tumour response observed from longitudinal imaging supports the decision to progress this candidate into an earlier line of therapy.
My take: The release states TLX101 is currently second line...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.05 |
Change
-0.190(1.25%) |
Mkt cap ! $4.973B | |||
| Open | High | Low | Value | Volume |
| $15.25 | $15.46 | $15.01 | $19.15M | 1.257M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3385 | $15.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.16 | 8704 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.02 |
Change
-0.190 ( 1.12 %) |
||||
| Open | High | Low | Volume | ||
| $15.33 | $15.46 | $15.02 | 192620 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| TLX (ASX) Chart |